Should you buy growth stocks right now?

It depends on when you might need to use the money from your investment.

| More on:
Person pointing at an increasing blue graph which represents a rising share price.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

It's a scary time to be a growth investor. With the Federal Reserve aggressively hiking interest rates and the stock market in a steady decline, it's entirely rational to wonder whether it's a good idea to keep buying shares of growth-phase businesses. 

And (spoiler alert) for some people, it might not be. Much depends on your risk tolerance and investment time frame. Let's examine Teladoc Health (NYSE: TDOC) as an example to explore which category of investor you might fall into during the ongoing disruption in the market and the economy.  

The pro case: Why it makes sense to keep buying shares

Like many other growth stocks, Teladoc is down more than 88% over the last 12 months. This brutal decline might seem like the kind of result you'd expect from a company with shrinking revenue or severe and enduring headwinds, but neither is the case. Its quarterly revenue rose by around 25% over the last four quarters, and over the last three years, its quarterly sales increased by 334%. 

But while growth has somewhat slowed compared to prior years, it's hardly a foregone conclusion that it will slow further or start contracting. Teladoc is expanding its telehealth offerings to include chronic care management and mental healthcare, both of which are anticipated to be lucrative areas as more wellness services offer telemedicine. And there's no single telehealth provider that's as big or as well-known, another advantage that might become more relevant over time. 

Let's say that you're a relatively young investor with a high tolerance for risk and a need for aggressive stocks to deliver big growth in your portfolio. The fact that Teladoc's shares have been eating dirt recently shouldn't really influence your decision as the decline isn't associated with any detrimental changes to its competitive advantage in the market. The stock's poor performance is also not the result of consumers eschewing telehealth as a category of services. 

Though it's true that the Federal Reserve's policy of hiking interest rates will make it a bit more expensive for Teladoc to borrow money moving forward, the same is true for most growth stocks that might need to take out a loan. And as much as inflation and supply chain issues might be striking the economy, Teladoc's most critical inputs are skilled labor from its telemedicine physicians, who don't need specific supplies to continue to add value, and whose services are already on the expensive side.  

In other words, the stock market's present headwinds aren't going to stop Teladoc from continuing to do what it's best at in the long run. So if you're willing to accept a bit of turbulence in the short term, the main investing thesis for Teladoc is still sound, and you should keep buying shares.

Furthermore, there's a very high chance that quite a few other growth stocks that are currently in the dumpster still have a similar combination of financial health and enduring competitive ability. If the company's prospects haven't significantly dimmed, the recent downward price movements might just be noise or fallout from the wider market -- not a reason to avoid investing. 

The con case: Why it might be better to wait or invest in something safer

Buying shares of a formerly high-flying growth stock like Teladoc is easy to do if you know you won't need the money anytime soon, or possibly ever. On the other hand, if you're an investor who needs to skew more conservatively because of a looming financial goal like retirement or financial independence, the picture is a bit different.

While unlikely, it's entirely possible that Teladoc's shares will drop by another 88% over the next couple of years, even if its competitive abilities only become stronger. And an investment in a beaten-down growth stock that might take five or six years to recover simply won't do if you need the money before then.

Additionally, rapidly expanding businesses in new industries like telehealth will frequently face competition from new entrants to the market, who may ultimately eat their lunch. For a company like Teladoc that's presently unprofitable, the arrival of new competitors could make the march toward profits even longer and more difficult. The same might be true of other hot sectors.

Finally, if your portfolio needs less exposure to risk for any other reason, it's probably not a smart idea to invest in Teladoc or other highly hyped growth stocks. Even if the long-term future of the company and the market both look bright, by most accounts we're in for a bit more turbulence before things settle down. 

This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

Alex Carchidi has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Teladoc Health. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on International Stock News

Business woman watching stocks and trends while thinking
Share Market News

Following the US-China trade deal, is VTS ETF a more compelling investment?

is the US stock market back in favour?

Read more »

A woman sits in a cafe wearing a polka dotted shirt and holding a latte in one hand while reading something on a laptop that is sitting on the table in front of her
International Stock News

Prediction: This artificial intelligence (AI) stock could be the next Nvidia — and it's not what you think

Let's take a closer look at that name and see why it could turn out to be a solid addition…

Read more »

A woman in jeans and a casual jumper leans on her car and looks seriously at her mobile phone while her vehicle is charged at an electic vehicle recharging station.
International Stock News

Worried about Tesla's Robotaxi? These two words from Nvidia CEO Jensen Huang might change your mind.

Investors are on the edge of their seats as Tesla's robotaxi launch is reportedly around the corner.

Read more »

AI written in blue on a digital chip.
International Stock News

Warren Buffett has 23% of Berkshire Hathaway's portfolio invested in 2 AI stocks up 600% and 900% in the last decade

Here's what investors should know about these two stocks.

Read more »

Happy woman working on a laptop.
International Stock News

Want to invest in quantum computing? 3 stocks that are great buys right now.

They all give investors direct exposure to quantum computing, but aren't the all-or-nothing bets that some investors may regret going…

Read more »

A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.
International Stock News

Billionaire Dan Loeb just sold Meta and Tesla stocks and piled into this hot AI stock up 1,500% over the past 5 years

Let's see what investors are thinking about these stocks today.

Read more »

A head shot of legendary investor Warren Buffett speaking into a microphone at an event.
International Stock News

Warren Buffett just spent $1.8 billion on 7 stocks. Here's the best of the bunch

Buffett's relatively small investments could be big opportunities for individual investors.

Read more »

Woman and man calculating a dividend yield.
International Stock News

This monster streaming stock has quietly crushed Netflix in 2025. Could a stock split be on the horizon?

Streaming stocks have crushed the market this year, and one name in particular has blown Netflix out of the water.

Read more »